Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer-Reference-Cited by-同舟云学术

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

Published:2017-10 Issue:10 Volume:28 Page:2436-2442
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Azria D.,Doyen J.,Jarlier M.,Martel-Lafay I.,Hennequin C.,Etienne P.,Vendrely V.,François E.,de La Roche G.,Bouché O.,Mirabel X.,Denis B.,Mineur L.,Berdah J.,Mahé M.,Bécouarn Y.,Dupuis O.,Lledo G.,Seitz J.,Bedenne L.,Gourgou-Bourgade S.,Juzyna B.,Conroy T.,Gérard J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/10/2436/20232678/mdx351.pdf

Reference19 articles.

1. Recurrence and survival after total mesorectal excision for rectal cancer;Heald;Lancet,1986

2. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial;van Gijn;Lancet Oncol,2011

3. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma;Peeters;Ann Surg,2007

4. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study;Bosset;Lancet Oncol,2014

5. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer;Braendengen;J Clin Oncol,2008

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying societal burden of radiation-induced small bowel toxicity in patients with rectal cancer;Frontiers in Oncology;2024-07-08

2. Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer;The Cancer Journal;2024-07

3. Evaluating complete response rates and predictors in total neoadjuvant therapy for rectal cancer;Journal of Gastrointestinal Surgery;2024-07

4. Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort;Annals of Surgical Oncology;2024-06-09

5. Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy;JAMA Network Open;2024-06-04